DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

Referenz

Ambrose PG, Drusano GL, Craig WA.
In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humans.

Clin Infect Dis 2012;
54 (Suppl. 03) S220-S228

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: